http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b3a5566f31361cee614bfacaf90b533
Outgoing Links
Predicate | Object |
---|---|
family-name | Goedert |
name | James J. Goedert James J Goedert |
given-name | James J James J. |
organization-name | National Cancer Institute, 6130 Executive Blvd., EPN/434 Rockville, MD 20892 4Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland. National Cancer Institute, Bethesda, Maryland, USA From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville; and Center for Cancer Research, National Cancer Institute, Bethesda, MD; and Mayo Clinic, Rochester, MN. Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; C. Winkler, W. Modi, M. W. Smith, G. W. Nelson, X. Wu, M. Carrington, Science Applications International Corporation (SAIC), National Cancer Institute, Frederick, MD 21702, USA.; M. Dean and S. J. O'Brien, Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702, USA.; T. Honjo and D. Yabe, Department of Medical Chemistry, Kyoto University, Kyoto, Japan.; K. Tashiro, Center for Molecular Biology and Genetics, Kyoto University, Kyoto, Japan.; S. Buchbinder and E. Vittinghoff, AIDS Office, Department of Public Health, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102, USA. National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892 2 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. goedertj@mail.nih.gov Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Bethesda MD Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland 20892 Viral Epidemiology Branch, National Cancer Institute, Bethesda, Maryland From the Viral Epidemiology Branch, HIV and AIDS Malignancy Branch, and Experimental Retrovirology Section, National Cancer Institute, Bethesda, MD; the HIV Clinical Interface Laboratory, Science Applications International Corp-National Cancer Institute, Frederick, MD; and the Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto, Japan. Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA Division of Cancer Epidemiology and Genetics National Cancer Institute 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, United States National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Wellcome Trust Centre for the Epidemiology of Infectious Disease, Department of Zoology, South Parks Road, Oxford University, Oxford OX1 3PS, United Kingdom; Viral Epidemiology Branch, National Cancer Institute, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD 20852; Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064; and Institute for Advanced Study, Olden Lane, Princeton, NJ 88540 Intramural Research Support Program, SAIC–Frederick, National Cancer Institute, Frederick, MD 21702; Laboratories of Genomic Diversity and Molecular Immunoregulation, National Cancer Institute, Frederick, MD 21702; Rho, Inc., 121 South Estes Drive, Suite 100, Chapel Hill, NC 27514; Viral Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20892; Northwestern University Medical School, Comprehensive AIDS Center, 6980 North Lake Shore Drive, Suite 1106, Chicago, IL... Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland Infections and Immunoepidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD USA 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Medicine, The Johns Hopkins University, and 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland From the National Cancer Institute, Rockville, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 1Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD; 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland; From the National Institutes of Health, Bethesda, Maryland. Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, USA. goedertj@mail.nih.gov Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland J. J. Goedert, Viral Epidemiology Branch, NCI-Executive Plaza North, 6130 Executive Boulevard, Bethesda, MD 20892, USA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850; Viral Epidemiology Branch, NCI–Executive Plaza North, Bethesda, MD 20892, USA, for Multicenter Hemophilia Cohort Study. From the Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, the Laboratory of Pathology, and the Biostatistics Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD. Infectious and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, USA. From the HIV and AIDS Malignancy BranchMedicine Branch, and Biostatistics and Data Management Section, Division of Clinical Sciences; Division of Cancer Treatment and Diagnosis; Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda; Science Applications International Corporation, Frederick, MD. National Cancer Institute, Bethesda, Maryland Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20892, USA. Infectious and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA §Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852; 1Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland; From National Cancer Institute, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland. Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Science Applications International Corporation Frederick, National Cancer Institute, Frederick, MD 21702-1201; Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702-1201; Laboratory of Experimental Immunology, National Cancer Institute, Frederick, MD 21702-1201; Viral Epidemiology Branch, National Cancer Institute, Rockville, MD 20852; Johns Hopkins School of Hygiene and Public Health for AIDS Link to the Intravenous Experience, Baltimore, MD 21205; San Francisco... Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. Liver Group, Division of Infection, Inflammation, and Repair, Southampton University, Southampton 5016 6YD, UK.; Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.; Basic Research Program, Scientific Applications International Corporation Frederick, Inc., Laboratory of Genomic Diversity, NCI Frederick, Frederick, MD 21702, USA.; Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA.; New York Academy of Medicine, New York, NY 10029, USA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health US Department of Health and Human Services Bethesda Maryland USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH/Department of Health and Human Services, Bethesda, Maryland; Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, MD 20892. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA. Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Viral Epidemiology Branch, National Cancer Institute, Rockville, Maryland Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland and 2Johns Hopkins University, Baltimore, Maryland From the National Cancer Institute, Rockville, MD. Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland From Kaiser Permanente Northern California, Oakland, California; Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Center for Global Health, Lurie Cancer Center, and College of Medicine, University of Illinois at Chicago, Chicago, Illinois; National Cancer Institute, National Institutes of Health, Bethesda, Maryland;; University of California, San Francisco, San Francisco, California; Centers for Disease Control and Prevention, Atlanta, Georgia; Ontario HIV Treatment Network, Dalla Lana School of Public Health, and Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; University of Calgary, Calgary, Alberta, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada;; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; Mid-Atlantic Permanente Research Institute, Kaiser Permanente, Rockville, Maryland; University of Washington, Seattle, Washington; Oregon Health and Sciences University, Portland, Oregon; University of California, San Diego, San Diego, California; Retrovirus Research Center, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico;; School of Medicine, University of North Carolina, Chapel Hill, North Carolina; Vanderbilt University, Nashville, Tennessee; University of Alabama, Birmingham, Alabama; Veterans Affairs Connecticut Healthcare System and Yale University Schools of Medicine and Public Health, New Haven, Connecticut. National Cancer Institute, Bethesda and From the University of Cincinnati College of Medicine, OH; Pennsylvania State University, Hershey; Viral Epidemiology Branch, National Cancer Institute, Rockville, MD; and Beth Israel-Deaconess Medical Center, Harvard University, Boston, MA. Department of Medicine, St Louis University School of Medicine, St Louis, Missouri. M. W. Smith, M. Carrington, C. Winkler, D. A. Lomb, Science Applications International Corp. Frederick, National Cancer Institute, Frederick, MD 21702–1201, USA.; M. Dean, G. A. Huttley, S. J. O'Brien, Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702–1201, USA.; J. J. Goedert and T. R. O'Brien, Viral Epidemiology Branch, National Cancer Institute–Executive Plaza North, 6130 Executive Boulevard, Bethesda, MD 20892, USA.; L. P. Jacobson, Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health, Room E-7008, 615 North Wolfe Street, Baltimore, MD 21205–1999, USA.; R. Kaslow, Department of Epidemiology, University of Alabama at Birmingham, 720 South 20th Street, Tidwell Hall 212C, Birmingham, AL 35294, USA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Infections and Immunoepidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville MD USA |
Incoming Links
Total number of triples: 437.